Halpern, John H.

The pharmacology of lysergic acid diethylamide: A review

Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008) · CNS Neuroscience & Therapeutics

Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 455

Self‐treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)

Boyer, E. W., Babu, K. M., Adkins, J. E., McCurdy, C. R., & Halpern, J. H. (2008) · Addiction

Alkaloids: synthesis and pharmacologyOpioid Use Disorder Treatment

Cited by 343

A review of hallucinogen persisting perception disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD.

Halpern, J. H., Lerner, A. G., & Passie, T. (2016) · Current Topics in Behavioral Neurosciences

Psychedelics and Drug StudiesHallucinations in medical conditions

Cited by 133

Mitigation of post‐traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence

Passie, T., Emrich, H. M., Karst, M., Brandt, S. D., & Halpern, J. H. (2012) · Drug Testing and Analysis

Cannabis and Cannabinoid ResearchPosttraumatic Stress Disorder Research

Cited by 117

The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series

Karst, M., Halpern, J. H., Bernateck, M., & Passie, T. (2010) · Cephalalgia

Migraine and Headache StudiesPsychedelics and Drug Studies

Cited by 106

Do hallucinogens cause residual neuropsychological toxicity?

Halpern, J. H., & Pope, H. G. (1999) · Drug and Alcohol Dependence

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 82

Response to Tfelt-Hansen P: Is BOL-148 hallucinogenic?

Karst, M., Halpern, J., Bernateck, M., & Passie, T. (2011) · Cephalalgia

Migraine and Headache StudiesHallucinations in medical conditions

Cited by 4